NKD-31479-20596
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 850 / AZ
- Registered
- 2021-08-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-02
Registered in v-safe
-
2021-08-02
Dose 1 — Pfizer-BioNTech
- 2021-08-02
-
2021-08-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-05
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-07
-
2021-08-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-09
- 2021-08-16
-
2021-08-23
Dose 2 — Pfizer-BioNTech
- 2021-08-23
-
2021-08-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-08-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-28
- 2021-08-30
- 2021-09-08
- 2021-09-13
- 2021-09-20
- 2021-09-27
- 2021-10-06
- 2021-11-22
-
2022-02-21
Survey response — 6 months, dose 2MedDRA: Joint swelling, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Swelling in feet/anklesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-28
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-08-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-02 | Pfizer-BioNTech | No |
| 2 | 2021-08-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 2
Symptoms: Swelling in feet/ankles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Joint swelling | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release